EEG-synchronizing effect of gamma-hydroxybutyrate and 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) in relation to dopaminergic brain function.
D000161:Acoustic Stimulation; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism / Q000502:physiology*; D002395:Catecholamines / Q000378:metabolism; D003344:Cortical Synchronization; D003864:Depression, Chemical; D004050:Ditiocarb / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004569:Electroencephalography; D010134:Fenclonine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006885:Hydroxybutyrates / Q000494:pharmacology*; D008781:Methyltyrosines / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology*; D051381:Rats; D013378:Substantia Nigra / Q000502:physiology; D013997:Time Factors
D002395:Catecholamines; D006885:Hydroxybutyrates; D008781:Methyltyrosines; D011760:Pyrrolidinones; D004050:Ditiocarb; C001369:1-hydroxy-3-amino-2-pyrrolidone; D006220:Haloperidol; D010134:Fenclonine; D004298:Dopamine